We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UP icon
2801
Wheels Up
UP
$182M
$481K ﹤0.01%
7,014
-5,380
-43% -$208K
NSYS icon
2802
Nortech Systems
NSYS
$33.8M
$480K ﹤0.01%
50,959
+400
+0.8% +$3.52K
DDL
2803
Dingdong
DDL
$523M
$478K ﹤0.01%
318,400
+80,400
+34% +$153K
KRRO icon
2804
Korro Bio
KRRO
$196M
$474K ﹤0.01%
9,893
+1,259
+15% +$41.5K
HELE icon
2805
Helen of Troy
HELE
$704M
$472K ﹤0.01%
3,910
-124,300
-97% -$13.4M
KEN icon
2806
Kenon Holdings
KEN
$3.46B
$472K ﹤0.01%
19,400
-300
-2% -$6.52K
PRIM icon
2807
Primoris Services
PRIM
$4.48B
$472K ﹤0.01%
+14,210
New +$443K
PRME icon
2808
Prime Medicine
PRME
$560M
$472K ﹤0.01%
+53,292
New +$411K
SLN
2809
Silence Therapeutics
SLN
$648M
$471K ﹤0.01%
+27,102
New +$304K
FVCB icon
2810
FVCBankcorp
FVCB
$338M
$467K ﹤0.01%
32,875
+2,000
+6% +$24.2K
MTA
2811
Metalla Royalty & Streaming
MTA
$912M
$465K ﹤0.01%
151,100
-9,835
-6% -$29.3K
REFI
2812
Chicago Atlantic Real Estate Finance
REFI
$260M
$461K ﹤0.01%
28,500
-4,400
-13% -$67.1K
FINV
2813
FinVolution Group
FINV
$1.03B
$460K ﹤0.01%
93,900
ISTR icon
2814
Investar Holding Corp
ISTR
$426M
$460K ﹤0.01%
30,875
+5,700
+23% +$64.8K
REAX icon
2815
Real Brokerage
REAX
$523M
$460K ﹤0.01%
287,200
+173,917
+154% +$254K
GBX icon
2816
The Greenbrier Companies
GBX
$1.41B
$459K ﹤0.01%
10,394
-70,206
-87% -$2.75M
GNSS icon
2817
Genasys
GNSS
$78.8M
$459K ﹤0.01%
226,136
+64,000
+39% +$113K
SXI icon
2818
Standex International
SXI
$4.01B
$459K ﹤0.01%
+2,900
New +$417K
IYH icon
2819
iShares US Healthcare ETF
IYH
$3.75B
$458K ﹤0.01%
8,000
+3,500
+78% +$191K
DFGR icon
2820
Dimensional Global Real Estate ETF
DFGR
$3.85B
$457K ﹤0.01%
+17,600
New +$413K
SYRS
2821
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$457K ﹤0.01%
58,635
+9,400
+19% +$32.2K
KOPN icon
2822
Kopin
KOPN
$1.02B
$456K ﹤0.01%
224,702
-577,562
-72% -$825K
FSBC icon
2823
Five Star Bancorp
FSBC
$1.15B
$455K ﹤0.01%
17,364
+3,664
+27% +$80.4K
MRBK icon
2824
Meridian
MRBK
$240M
$455K ﹤0.01%
32,700
+700
+2% +$8.14K
AIOS
2825
AIOS Tech
AIOS
$39M
$455K ﹤0.01%
5,683
+4,360
+330% +$247K

Similar funds

Jim Simons's Q4 2023 Portfolio in Review

As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Jim Simons opened 702 new positions and closed 633 in Q4 2023.
  • Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.